Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Alyn Morice MD, FRCP, FBPhS

Prof. Alyn H. Morice MD, FRCP, FBPhS

Head Cardiorespiratory Studies, Hull York Medical School, University of Hull, Castle Hill Hospital, Cottingham, E Yorkshire, England

Alyn Hugh Morice, MD, FRCP, FBPhS, was appointed Foundation Chair and Professor and Head of Respiratory Research Group, Hull York Medical School, University of Hull in 1998. Cough has been described as the Cinderella symptom of respiratory disease and has been his main research interest.

He has pioneered investigation into the epidemiology, diagnosis and therapeutics of cough culminating in the production of national and ERS cough guidelines (ERJ 2020). His research on the neuronal mechanisms has radically altered our understanding leading to the concept of cough hypersensitivity. This has been translated by RCTs into therapeutic advances (opiates and P2X3 antagonists). Whilst overlapping with other respiratory disease, it is now recognised as a distinct condition (the cough hypersensitivity syndrome).